A detailed history of Boothbay Fund Management, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 409,070 shares of VRNA stock, worth $18.5 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
409,070
Previous 855,398 52.18%
Holding current value
$18.5 Million
Previous $12.4 Million 4.86%
% of portfolio
0.33%
Previous 0.37%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.46 - $30.16 $6.9 Million - $13.5 Million
-446,328 Reduced 52.18%
409,070 $11.8 Million
Q2 2024

Aug 14, 2024

BUY
$11.48 - $17.02 $2.48 Million - $3.68 Million
216,280 Added 33.84%
855,398 $12.4 Million
Q1 2024

May 15, 2024

BUY
$15.3 - $20.24 $8.74 Million - $11.6 Million
571,194 Added 840.93%
639,118 $10.3 Million
Q4 2023

Feb 14, 2024

BUY
$11.94 - $20.47 $140,008 - $240,031
11,726 Added 20.87%
67,924 $1.35 Million
Q3 2023

Nov 14, 2023

BUY
$16.3 - $22.09 $80,098 - $108,550
4,914 Added 9.58%
56,198 $916,000
Q2 2023

Aug 14, 2023

BUY
$19.41 - $23.43 $336,239 - $405,877
17,323 Added 51.01%
51,284 $1.08 Million
Q1 2023

May 15, 2023

SELL
$18.06 - $25.27 $70,939 - $99,260
-3,928 Reduced 10.37%
33,961 $681,000
Q4 2022

Feb 14, 2023

SELL
$9.84 - $26.13 $87,674 - $232,818
-8,910 Reduced 19.04%
37,889 $990,000
Q3 2022

Nov 14, 2022

BUY
$4.14 - $13.59 $35,268 - $115,773
8,519 Added 22.25%
46,799 $478,000
Q2 2022

Aug 15, 2022

BUY
$3.55 - $5.06 $135,894 - $193,696
38,280 New
38,280 $160,000

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.76B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.